Cenobamate use results in unprecedented seizure freedom rates for patients 1PARIS (BUSINESS WIRE) Angelini Pharma, international pharmaceutical company part of the privately held Italian Angelini Group announced today that ONTOZRY® (cenobamate) is now available in the Netherlands for the adjunctive treatment of fo.
On the occasion of World Epilepsy Day (14th of February 2022), Angelini Pharma, international Italian pharmaceutical company, is committed to provide patients and healthcare professionals with innovative
On the occasion of World Epilepsy Day (14th of February 2022), Angelini Pharma, international Italian pharmaceutical company, is committed to provide patients and healthcare professionals with innovative solutions improving the care of patients with epilepsy .
What connects this diverse group of persons: Julius Caesar, Fyodor Dostoevsky, the singer Prince, Susan Boyle and US Chief Justice John Roberts? They have all experienced one of the most misunderstood, maligned and stigmatising medical conditions – epilepsy.
Persons with epilepsy have been unfairly singled out, prosecuted and discriminated by various cultures and societies across the millennia. Persons with epilepsy have been and still are unjustly perceived as being possessed by magic or supernatural power, despite it being so common. It affects around one per cent of the population worldwide, across all ages.
This means that around 4,000 persons in Malta have epilepsy. One cannot stress enough that a person is not ‘epileptic’ or ‘suffers from epilepsy’, since such terms reinforce the stigmatisation.